Demographics of patients with ABO antigen weakness
| . | Total (n = 511) . | A weak (n = 172) . | B weak (n = 309) . | Both (n = 30) . |
|---|---|---|---|---|
| Age, mean, y | 50.4 | 50.7 | 50.5 | 47.7 |
| Sex | ||||
| Male | 250 (48.9%) | 90 (52.3%) | 144 (46.4%) | 16 (53.3%) |
| Female | 261 (51.1%) | 82 (47.7%) | 165 (53.4%) | 14 (46.7%) |
| Clinical status | ||||
| Malignancy | 145 (28.4%) | 45 (26.2%) | 93 (30.1%) | 7 (23.3%) |
| Chemotherapy | 82 (16.0%) | 31 (18.0%) | 41 (13.3%) | 10 (33.3%) |
| Hematologic diseases | 103 (20.2%) | 55 (32.0%) | 32 (10.4%) | 16 (53.3%) |
| Pregnancy | 18 (3.5%) | 4 (2.3%) | 13 (4.2%) | 1 (3.3%) |
| Healthy | 47 (9.2%) | 12 (7.0%) | 33 (10.7%) | 2 (6.7%) |
| . | Total (n = 511) . | A weak (n = 172) . | B weak (n = 309) . | Both (n = 30) . |
|---|---|---|---|---|
| Age, mean, y | 50.4 | 50.7 | 50.5 | 47.7 |
| Sex | ||||
| Male | 250 (48.9%) | 90 (52.3%) | 144 (46.4%) | 16 (53.3%) |
| Female | 261 (51.1%) | 82 (47.7%) | 165 (53.4%) | 14 (46.7%) |
| Clinical status | ||||
| Malignancy | 145 (28.4%) | 45 (26.2%) | 93 (30.1%) | 7 (23.3%) |
| Chemotherapy | 82 (16.0%) | 31 (18.0%) | 41 (13.3%) | 10 (33.3%) |
| Hematologic diseases | 103 (20.2%) | 55 (32.0%) | 32 (10.4%) | 16 (53.3%) |
| Pregnancy | 18 (3.5%) | 4 (2.3%) | 13 (4.2%) | 1 (3.3%) |
| Healthy | 47 (9.2%) | 12 (7.0%) | 33 (10.7%) | 2 (6.7%) |